Clinical trial
The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
NCT00406926 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00406926 |
|---|---|
| Title | The Effect of Growth Hormone in Very Young Girls With Turner Syndrome |
| Official title | The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Turner Syndrome |
| Intervention type | Drug |
| Interventions | Somatropin |
| Enrollment | 100 |
| Start date | Aug 1, 1999 |
| Completion | Aug 1, 2003 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 4, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: